Small Cap Stocks Gain Traction: MustGrow Biologics, Ocean Power Technologies, Medicus Pharma, Candel Therapeutics, Digi Power X, and G Mining Ventures Lead the Way

Noble Capital Markets analysts highlighted MustGrow Biologics' growing commercial traction following its Q2 results, citing the early success of its TerraSante biofungicide. Ocean Power Technologies is shipping two unmanned surface vehicles to the UAE and expanding its presence in the region. Medicus Pharma completed its acquisition of Antev Limited, a UK-based clinical-stage drug development company. Candel Therapeutics appointed Dr. Carl June to its Research Advisory Board, and Digi Power X increased its digital asset holdings and provided an update on its strategic shift toward AI infrastructure. G Mining Ventures received an environmental permit for its Oko West Gold Project in Guyana. Meren Energy announced changes to its executive leadership team.

MustGrow Biologics (OTCQB: MGROF) reported robust Q2-2025 financial results, showcasing the early success of its TerraSante biofungicide. The company achieved $2.8 million in revenue, a significant increase from the $0 revenue reported in Q2-2024. This growth was driven by sales of TerraSante™ biofertility products in the U.S., which tripled the entire 2024 sales volume. The company's gross profit margin improved to 20.9% in Q2-2025, up from 14.3% in Q1-2025, reflecting the strong demand for its products [1].

MustGrow's financial position remains stable, with $1.8 million in cash and equivalents and $1.8 million in inventory as of June 30, 2025. Despite a net loss of $1.1 million, or $0.02 per basic share, the company is optimistic about its future prospects. The company plans to expand its TerraSante™ sales and produce more inventory to meet growing demand. Additionally, MustGrow's Canadian sales and distribution division, NexusBioAg, is expected to perform strongly in the fourth quarter of 2025 [1].

Ocean Power Technologies (NYSE American: OPTT) announced the shipment of two WAM-V® Unmanned Surface Vehicles (USVs) to Remah International Group (RIG), a UAE-based military services company. This shipment strengthens OPT's presence in the Middle East region and highlights its expeditionary capabilities and ability for autonomous ocean operations. OPT plans to establish a sales and operations office in the UAE and make strategic hires to support its expansion in the region [2].

Medicus Pharma completed its acquisition of Antev Limited, a UK-based clinical-stage drug development company. The acquisition expands Medicus Pharma's capabilities in drug development and enhances its research and development portfolio. Candel Therapeutics appointed Dr. Carl June to its Research Advisory Board, signaling a strategic shift toward innovative clinical research. Digi Power X increased its digital asset holdings and provided an update on its strategic shift toward AI infrastructure, positioning itself for growth in the AI sector. G Mining Ventures received an environmental permit for its Oko West Gold Project in Guyana, marking a significant milestone in the company's exploration and development efforts. Meren Energy announced changes to its executive leadership team, aiming to drive operational efficiency and strategic growth [3].

References:
[1] https://www.stocktitan.net/news/MGROF/must-grow-announces-record-q2-2025-results-2-8-million-revenue-and-wjg5wd539q6v.html
[2] https://www.stocktitan.net/news/OPTT/ocean-power-technologies-announces-shipment-of-wam-vs-to-the-y0ce6ugfx0zb.html